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a b s t r a c t
The RAB5 gene family is the best characterised of all human RAB families and is essential for in vitro
homotypic fusion of early endosomes. In recent years, the disruption or activation of Rab5 family
proteins has been used as a tool to understand growth factor signal transduction in whole animal
systems such as Drosophila melanogaster and zebraﬁsh. In this study we have examined the functions for
four rab5 genes in zebraﬁsh. Disruption of rab5ab expression by antisense morpholino oligonucleotide
(MO) knockdown abolishes nodal signalling in early zebraﬁsh embryos, whereas overexpression of
rab5ab mRNA leads to ectopic expression of markers that are normally downstream of nodal signalling.
By contrast MO disruption of other zebraﬁsh rab5 genes shows little or no effect on expression of
markers of dorsal organiser development. We conclude that rab5ab is essential for nodal signalling and
organizer speciﬁcation in the developing zebraﬁsh embryo.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Cellular motility and cohesion are essential processes in verte-
brate early embryonic development. Integral to the processes are
intracellular trafﬁcking events, which direct the signalling between
cells and the movement and adhesion of cells. Intracellular signal-
ling is, in turn, heavily dependent on vesicle transport events, under
the control of RAB proteins, which localise to speciﬁc intracellular
compartments and pilot vesicles to target membranes (Zerial and
McBride, 2001).
The RAB family of small GTPase enzymes is the largest sub-
family in the Ras super-family. RABs are found in all eukaryotes,
with 64 (including 4 pseudogenes) RAB genes present in the
human reference genome (Zerial and McBride, 2001; Colicelli,
2004; Seal et al., 2011). The current thinking is that ﬁve core RABs
are required for the basic functions of a cell, RAB1, RAB5, RAB6,
RAB7 and RAB11 (Chavrier et al., 1990; Bucci et al., 1992; Pereira-
Leal and Seabra, 2001). The RAB5 family is perhaps the best
characterised of all 43 human RAB families and its members have
been shown to localize to clathrin-coated vesicles, early endo-
somes and the plasma membrane (Bucci et al., 1992). The proteins
are essential for in vitro homotypic fusion of early endosomes
and are able to increase the rate of endocytosis in vivo when
overexpressed (Gruenberg and Howell, 1989; Gorvel et al., 1991;
Li and Stahl, 1993).
For cell and developmental biology much interest in Rab5
activity has resulted from their use as a tool to alter endocytosis.
For example, activation and disruption of Rab5 proteins have been
used to understand cell movements during gastrulation and how
signalling factors move though a developing embryo (Scholpp and
Brand, 2004; Ulrich et al., 2005; Hagemann et al., 2009; Tay et al.,
2010; Torres and Stupack, 2011). Similarly, Rab5 proteins have also
been used to understand human diseases such as Alzheimer's
disease (Ginsberg et al., 2010) and the motility and invasiveness of
tumour cells (Torres and Stupack, 2011).
There are three mammalian RAB5s: RAB5A, RAB5B and RAB5C,
which have been studied in mammalian cell culture assays (Wilson
and Wilson, 1992; Singer-Kruger et al., 1994). Normally, such studies
do not distinguish individual RAB5 gene activities (Bernard et al., 2010;
Hagiwara et al., 2011), though other cell-based studies have shown
that each member of the family can differentially regulate trafﬁcking
(Baskys et al., 2007; Chen et al., 2009). For example, RAB5 proteins are
differentially recognised by different kinases (Chiariello et al., 1999).
RAB5A is efﬁciently phosphorylated by extracellular-regulated kinase
1 but not by extracellular-regulated kinase 2, while cdc2 kinase
preferentially phosphorylates Ser-123 of RAB5B. It was suggested that
phosphorylation could be important to differentially regulate the
function of the RAB5 isoforms (Chiariello et al., 1999).
In whole-animal studies of development, Rab5 family proteins
have been used as a tool to understand trafﬁcking of growth
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factors and their signals (Scholpp and Brand, 2004; Ulrich et al.,
2005; Hagemann et al., 2009). In these studies, however, indivi-
dual family members are rarely distinguished and sometimes used
interchangeably. Given that cell culture studies have suggested
divergent roles for the various rab5 genes (Baskys et al., 2007;
Chen et al., 2009), one aim of this study was to assay in vivo for
differing roles of individual members of the rab5 gene family
during early embryonic development. Moreover, we sought to
understand how these effects are manifest in the dynamically
developing embryo, rather than as isolated signalling events, with
the overall aim of understanding how individual rab5 family genes
contribute to zebraﬁsh early developmental events such as dorsal
organiser speciﬁcation.
Materials and methods
Probe synthesis and in situ hybridisation
Whole-mount in situ hybridisation was carried out essentially as
described by Thisse and Thisse (2008). The rab5aa gene probe was
transcribed directly from cDNA clone IMAGp998K098962Q (Source
BioScience) and linearized with Sal1 (NEB) and transcribed with SP6
RNA polymerase (NEB). Embryos were manually dechorionated and
ﬁxed in 4% paraformaldehyde at 24 h post fertilisation (hpf).
50 capped RNA synthesis
Capped rab5ab RNA was synthesised in vitro using 5 mg (5 ml) of
linearized rab5ab DNA (IRAKp961M19104 sub-cloned into a
pCS2þ vector or a GFP-pCS2þvector) in a 50 ml reaction contain-
ing 10 ml of 5 transcription buffer, 5 ml of 0.1 M DTT, 5 ml of 5 mM
CAP (NEB), 5 ml of 1 mM GTP (NEB), 5 ml of 5 mM UTP (NEB), 5 ml of
5 mM ATP (NEB), 5 ml of 5 mM CTP (NEB), 2 ml of RNAse inhibitor
(NEB) and 3 ml of SP6 RNA polymerase (NEB) incubated at 37 1C for
20 min when 4 ml of 10 mM GTP was added and incubated at 37 1C
for a further 2 h. An additional 3 ml of RNAse free DNAse (Promega)
was added and the reaction incubated at 37 1C for a further
20 min. The RNA was separated from the other reaction compo-
nents using Chroma-100 spin columns (Clontech).
MO injections
The following MOs (Genetools) were used in this study:
rab5aa MO 50-GACAGTTGTCAATCACCCCGTCTTC,
rab5ab MO 50-TCGTTGCTCCACCTCTTCCTGCCAT,
rab5ab MO2 50-GACCCAAAACCCCAATCTCCTGTAC,
rab5ab (MM) 5 bp mismatch 50-GACgCAAAAgCCgAATCTgCT-
cTAC,
rab5ab splice MO: 50-ATGAAGCGTTTGTCTTACCTCCTAT
rab5b MO 50-CCTGCCTGTCCCACGGGTACTCATG,
rab5c MO 50-CGCTGGTCCACCTCGCCCCGCCATG,
Standard Control MO 50-CCTCTTACCTCAGTTACAATTTATA.
p53 MO: GCGCCATTGCTTTGCAAGAATTG
Oligonucleotides were diluted in MO buffer (5 mg/ml phenol
red (Sigma), 4 mM HEPES pH 7.2 (Sigma), 160 mM KCl (Sigma))
and 1.4 nl of MO solution was injected into the yolk of the 1–4 cell
stage embryo. We used 10 ng of rab5aa MO, 3 ng or 5 ng of rab5ab
MO, 8 ng for rab5b MO, 6 ng for rab5c MO and those quantities
with an additional 2 ng for standard control MO injections.
Electron microscopy
Whole zebraﬁsh embryos were dechorionated manually and
ﬁxed overnight with 2% glutaraldehyde, 2% paraformaldehyde in
0.1 M sodium cacodylate buffer (pH 7.2) (SCB). The following day,
embryos were washed for 10 min in SCB and post-ﬁxed for 1 h in
1% osmium tetroxide in SCB. They were washed again with SCB
and stained en bloc with 1% aqueous uranyl acetate for 1 h. The
samples were then dehydrated through a graded ethanol series,
followed by two changes of propylene oxide over 20 min and
embedded in Epon resin (Agar Scientiﬁc). We then cut 50 nm
ultra-thin sections, mounted them on pioloform coated slot grids
and stained with 1% aqueous uranyl acetate for 15 min, followed
by Reynold's lead citrate for 7 min. Sections were visualised in a
Jeol 1200 EX electron microscope.
Epiboly movement assay
Embryos were dechorionated at dome stage, 30% epiboly or
shield stage then placed in glass dishes containing 5 mg/ml of
biotinylated-dextran (Molecular probes 10,000 mw lysine ﬁx-
able) in 1 Danieau solution for 20 min (Shih and Fraser, 1996).
Embryos were then washed and ﬁxed in 4% paraformaldehyde
solution. Fixed embryos were dehydrated in methanol then
rehydrated in PBT (10 mM phosphate buffered saline, 0.05%
Tween-20, pH 7.4) and incubated for 30 min in 1:5000 horse-
radish peroxidase-labelled streptavidin in PBT. Embryos were
washed three times with PBT and soaked for 30 min in DAB/PBT
Fig. 1. rab5 family shows conservation between species (A) Stylised version of the
RAB5 family tree constructed using Genomicus version 61.01 (Muffato et al., 2010).
Bootstrap (%) values are shown for tree nodes; red¼gene duplication (paralogues);
blue¼speciation (orthologues). (B) Conservation of RAB5A protein sequence
between human, mouse, zebraﬁsh and stickleback. (C) Conservation of RAB5B
protein sequence between human, mouse, zebraﬁsh and stickleback.
(D) Conservation of RAB5C protein sequence between human, mouse, zebraﬁsh
and stickleback. Conservation percentage identity matrix produced by Clustal
Omega (Sievers et al., 2011).
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(0.4 mg/ml 3,30-Diaminobenzidine in PBT). The solution was
then changed for staining solution, DAB/PBT with 0.003% H2O2,
and examined as reaction product developed over 30 min. Once
stained the reaction was stopped by rinsing with PBT.
RT-PCR
RNA was isolated from control and rab5ab MO injected
embryos using Trizol as per manufacturers protocol (Invitrogen).
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We used 1.5 μg of RNA to produce cDNA by reverse transcription
(Superscript III, Life Technologies). Quantitative PCR was per-
formed using Applied Biosystems TaqMan Universal PCR Master
Mix and TaqMan primers for ndr1, gsc, ntl, chd, tfr1b, wnt8a, bmp2b
and bmp4 designed and made by Applied Biosystems on an ABI
prism using 7000 system software. Each of the cDNAs, ndr1, ntl,
gsc, chd, tfr1b, wnt8a, bmp2b and bmp4 were analysed separately.
Preliminary inspection supported normalisation of the cycle
threshold (Ct) data transformation by 1/log2(Ct) to stabilise var-
iances and allow intuitive visualisation using box-whisker plots.
Such a transformation allows intuitive interpretation of changes in
gene expression (a difference of one equates to a two fold change
in expression), with further reciprocal transformation stabilising
the mean-variance relationship (Eastwood et al., 2008; Bull et al.,
2012). Expression of tfr1b was shown not to change between
control and MO injected embryos (L.R.¼0.097, p¼0.76) but did
change between stage (L.R.¼13.4, po0.001, 30% v shield stage)
therefore all other genes were normalised to tfr1b within stage.
The transformed data were analysed using linear mixed-effects
models (Pinheiro and Bates, 2000) with MO-injected versus con-
trol embryos as a categorical ﬁxed effect and the experimental
design captured as hierarchical random effects, with technical
replication (RNA preparations) nested within biological replication
(individual embryos). Hypotheses on the effects of MO injections
were tested using likelihood ratios, with the test statistic assumed
to be Chi-squared distributed (Pinheiro and Bates, 2000). R soft-
ware was used for calculations and graph generation (R Core
Development Team, 2008).
Phalloidin labelling
At 48 h post fertilisation (hpf) zebraﬁsh embryos were ﬁxed
in 4% PFA overnight. Embryos were washed in PBS-triton and incubated
in the dark with gentle agitation at room temperature overnight in
2.5 ug/ul Rhodamine phalloidin (Molecular Probes R415). Embryoswere
repeatedly washed in PBS-tween and imaged on an agarose plate using
a Nikon SMZ800 ﬂuorescent stereomicroscope and camera.
Results
Identiﬁcation of zebraﬁsh homologues of Human RAB5A, RAB5B and
RAB5C
The three RAB5 genes in humans were used as query sequence
to identify zebraﬁsh Ensembl predictions (Ensembl Zebraﬁsh
19.3.2) (Flicek et al., 2011), which was based on the zebraﬁsh
genome assembly (Zv3)(Howe et al., 2013), mRNAs and ESTs using
WU-BLAST followed by MSPcrunch ﬁltering (Sonnhammer and
Durbin, 1994). We used a threshold of 60% identity as a human to
zebraﬁsh match. Zebraﬁsh EST sequences were retrieved along
with capillary sequence traces (http://www.ncbi.nlm.nih.gov/
Traces/), if available, which were quality clipped and vector
masked with PreGap (Bonﬁeld and Staden, 1996). These were then
used to assemble cDNAs and ESTs in Gap4 (Bonﬁeld et al., 1998)
giving a total of four zebraﬁsh rab5 genes with recent genome
assembly's not revealing any further orthologs. These four rabs are
currently known as rab5aa (ENSDARG00000018602, ZDB-GENE-
030131-139), rab5ab (ENSDARG00000007257, ZDB-GENE-040122-
3), rab5b (ENSDARG00000016059, ZDB-GENE-040426-2593) and
rab5c (ENSDARG00000026712, ZDB-GENE-031118-30). The rab5ab
gene generates at least two coding variants while rab5aa, rab5b
and rab5c have only one annotated coding variant each. Using
Genomicus version 61.01 (Muffato et al., 2010) and conﬁrmed by
Ensembl release 62 we ﬁnd that the rab5a duplication is likely to
have resulted from the teleost speciﬁc whole-genome duplication,
as similarly duplicated rab5a genes are also present in the
Tetraodon, Medaka and Stickleback genomes (Fig. 1).
Morphological loss of function screen of rab5 family
To determine whether the rab5 genes in the zebraﬁsh genome
have similar functions, we knocked down each individually, using
MOs targeting the ATG start codon followed by morphological
phenotyping of the MO injected embryos (Nasevicius and Ekker,
2000).
rab5aa
rab5aa MO-injected embryos (n¼63/63) were morphologically
indistinguishable from control-injected embryos (n¼54/54). Due
to a lack of obvious phenotype, we studied the expression pattern
of rab5aa in detail. Before 24 hpf, rab5aa mRNA expression was
found to be low and uniform throughout all tissues (data not
shown). At 24 hpf, however, rab5aa mRNA was expressed in a
subset of cells in the brain especially in the ventral anterior part of
the neural tube, forebrain and midbrain region (Fig. 2(A)). Addi-
tionally, we found rab5aa mRNA expression in a bilateral patch of
telencephalic cells (Fig. 2(B)). The hindbrain showed expression in
the central region of each rhombomere (Fig. 2(C)), in cells in the
outer region of the neural tube at the midbrain/hindbrain bound-
ary (arrow in Fig. 2(D)) and at the posterior end of the hindbrain
Fig. 2. Expression and loss of function of the rab5a family. (A) Expression of rab5aa in the forebrain and midbrain region of a 24 hpf embryo. (B) Forebrain region with dorsal
focus showing two patches of bilateral telencephalic cells. (C) Hindbrain region showing expression on the central region of each rhombomere. (D) Expression of rab5aa in
cells outside the neural tube at the level of the midbrain/hindbrain boundary (arrow). (E) Expression of rab5aa at the end of the hindbrain (arrows) and in the trunk of the
embryo. (F) Side view of a 24 hpf embryo injected with 10 ng of control MO (n¼205/207). (G) Side view of a 24 hpf embryo injected with 8 ng of rab5b MO (n¼141/143).
(H) Side view of a 48 hpf embryo injected with 10 ng of control MO (n¼204/204). (I) Side view of a 48 hpf embryo injected with 8 ng of rab5bMO (n¼117/126). (J) Side view
of a 24 hpf embryo injected with 12 ng of p53 MO (n¼77/85). (K) Side view of a 24 hpf embryo co-injected with 12 ng of p53 MO and 8 ng of rab5b MO (n¼98/108) (L) Side
view of a 48 hpf embryo injected with 12 ng of p53 MO. (M) Side view of a 48 hpf embryo co-injected with 12 ng of p53 MO and 8 ng of rab5b MO (n¼52/62).
(N) Magniﬁcation of trunk region showing somites and notochord in 48 hpf control-injected embryos. (O) Magniﬁcation of trunk region showing somites and notochord in
48 hpf rab5b MO-injected embryos. (P) Magniﬁcation of trunk region showing somites in a 48 hpf control-injected embryo stained with phalloidin. (Q) Magniﬁcation of
trunk region showing somites in a 48 hpf rab5bMO-injected embryo stained with phalloidin. (R) Magniﬁcation of trunk region showing somites and notochord in 48 hpf p53
MO injected embryos. (S) Magniﬁcation of trunk region showing somites and notochord in 48 hpf p53 MO and rab5b MO co-injected embryos. (T) Magniﬁcation of trunk
region showing somites in a 48 hpf p53 MO injected embryo stained with phalloidin. (U) Magniﬁcation of trunk region showing somites in a 48 hpf p53 MO and rab5b MO
co-injected embryo stained with phalloidin. (V) Lateral view of a 30 hpf embryo injected with 5 ng of control MO (n¼92/95). (W) Lateral view of a 30 hpf embryo injected
with 6 ng of rab5c MO (n¼174/175). (X) Lateral view of a 48 hpf embryo injected with 5 ng of control MO (n¼92/95). (Y) Lateral view of a 48 hpf embryo injected with 6 ng
rab5c MO (n¼158/159). (Z) Lateral view of a 30 hpf embryo injected with 9 ng of p53 MO (n¼54/54). (AA) Lateral view of a 30 hpf embryo co-injected with 9 ng of p53 MO
and 6 ng of rab5c MO (n¼n¼54/56). (AB) Lateral view of a 48 hpf embryo injected with 9 ng of p53 MO. (AC) Lateral view of a 48 hpf co-injected with 9 ng of p53 MO and
6 ng of rab5c MO (n¼37/48). (AD) Magniﬁcation of trunk region showing somites and notochord in 48 hpf control-injected embryos. (AE) Magniﬁcation of trunk region
showing somites and notochord in 48 hpf rab5c MO-injected embryos. (AF) Magniﬁcation of trunk region showing somites in a 48 hpf control-injected embryo stained with
phalloidin. (AG) Magniﬁcation of trunk region showing somites in a 48 hpf rab5c MO-injected embryo stained with phalloidin. (AH) Magniﬁcation of trunk region showing
somites and notochord in 48 hpf p53 MO injected embryos. (AI) Magniﬁcation of trunk region showing somites and notochord in 48 hpf p53 MO and rab5c MO co-injected
embryos. (AJ) Magniﬁcation of trunk region showing somites in a 48 hpf p53 MO injected embryo stained with phalloidin. (AK) Magniﬁcation of trunk region showing
somites in a 48 hpf p53 MO and rab5c MO co-injected embryo stained with phalloidin. (A, B, D, E are dorsal views, anterior to the left and the eyes were manually removed
for simpliﬁcation C is a side view, anterior to the left (‘ov’ indicates otic vesicle).
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(arrows in Fig. 2(E)), which may correspond to expression in the
anterior and posterior lateral line, respectively. Expression could
also be seen in trunk region (Fig. 2(E)) showing positive cells
scattered in the dorsal half of the embryo.
rab5b
At 24 hpf, rab5b MO-injected embryos showed thin and bar-
shaped somites, as well as brain abnormalities. Speciﬁcally we found
reduced forebrain and general brain necrosis (Fig. 2(G)), when
compared to control-injected embryos (Fig. 2(F)). Double-injected
rab5b MO / p53 MO embryos showed the same curved axis and
bar-shaped somites (Fig. 2(K)) as rab5b MO single-injected embryos
(Fig. 2(G)) but with slightly fewer brain defects and less necrosis at
24 hpf. By 48 hpf rab5b MO-injected embryos showed a reduced and
curved axis with curved notochord (Fig. 2(I)), more pronounced bar-
shaped somites (Fig. 2(O)) and disrupted muscle ﬁbres (Fig. 2(Q))
when compared to control-injected embryos (Fig. 2(H), (N) and (P)).
When control and rab5b MO-injected embryos were co-injected with
the p53 MO, both control and p53 MO injected embryos (Fig. 2(J))
appeared similar to control embryos (Fig. 2(F)). By 48 hpf, rab5b MO/
p53 MO double-injected embryos injected embryos showed similar
reduced and curved axis with curved notochord (Fig. 2(M)) and
pronounced bar-shaped somites (Fig. 2(S)) as rab5b MO-injected
embryos (Fig. 2(I), (O) and (Q)). Additionally, rab5b MO / p53 MO
double-injected embryos showed reduced head size (Fig. 2(M)) and
disrupted muscle ﬁbres (Fig. 2(U)).
rab5c
Similar to rab5b MO-injected embryos, rab5c MO-injected
embryos showed U-shaped somites, shortened axis, forebrain
defects and brain necrosis, with the head region appearing poorly
developed at 24 hpf (Fig. 2(W)) when compare to control-injected
embryos (Fig. 2(V)). On the second day of development, rab5c
MO-injected embryos continued to develop poorly, with reduced
head size, shorter axis and curved tail (Fig. 2(Y)), when compared
to control-injected embryos (Fig. 2(X)). Additionally, in rab5c MO-
injected embryos muscle ﬁbres failed to align as smoothly
(Fig. 2(AG)) and notochord cells failed to form proper vacuoles
(Fig 2AE) when compared to controls (Fig. 2(AD) and (AF)). When
the control and rab5c MO-injected embryos were co-injected with
the p53 MO the control and p53 MO injected embryos (Fig. 2(Z))
looked similar to control embryos (Fig. 2(V)). The rab5c MO and
p53 MO injected embryos showed the same curved axis, U-shaped
somites, forebrain defects and brain necrosis (Fig. 2(AA)) as rab5c
MO-injected embryos (Fig. 2(W)) at 24 hpf. By 48 hpf rab5c MO
and p53MO injected embryos were more adversely affected with a
more pronounced curved axis and poorly developed head region
(Fig. 2(AC)) than rab5b MO-injected embryos (Fig. 2(Y)). Double-
injected rab5c MO / p53 MO embryos showed similar U-sha-
ped somites (Fig. 2(AI)) and more disorganised muscle ﬁbres
(Fig. 2(AK)) than embryos injected with rab5c MO alone (Fig. 2
(AE) and (AG))
rab5ab
In contrast to rab5aa, knockdown of rab5ab produced a strik-
ing morphological phenotype during gastrulation. Speciﬁcally
MO-injected embryos did not develop a dorsal organizer and died
before the completion of epiboly (Fig. 3(B)). Development was
dramatically slowed (Fig. 3(B)) in comparison with controls
(Fig. 3(A)). Injection of 5 ng of rab5ab MO resulted in the embryos
dying at between 30% and 50% epiboly. At 30% epiboly ﬂuid had
accumulated between blastoderm cells and the yolk cell (Fig. 3(B)). In
these embryos, the cells of the blastoderm appeared substantially
grainier in texture and less cohesive (Fig. 3(B)), when compared with
the smooth blastoderm of the control-injected embryos (Fig. 3(A)) and
stage matched control embryos (Fig. 3(C)). Further decreasing the
dose of rab5ab MO to 3 ng (Fig. 3(E), (G), (I), (K)) resulted in rab5ab
MO-injected embryos surviving to 80–90% epiboly (Fig. 3(K)).
Embryos injected with rab5ab MO underwent a slowed epiboly
(Fig. 3(E), (G), (I), (K)). Control embryos, however, underwent epiboly
at a constant rate over approximately 5 h (Fig. 3(D), (F), (H), (J)). By the
time control embryos reached 80% epiboly (Fig. 3(H)), MO-injected
embryos had only progressed to 50% epiboly (Fig. 3(I)) and when MO-
injected embryos eventually reached 80% epiboly (Fig. 3(K)), at 9 hpf,
control embryos were at the 7-somite stage (Fig. 3(J)). Although many
MO-injected embryos did not reach 80% epiboly, in cases where they
did, the blastoderm margin contracted and pinched off the yolk,
causing its contents to leak leading to the death of blastoderm cells. To
conﬁrm this phenotype we injected embryos with a second transla-
tion blocking MO to rab5ab (rab5abMO2) and compared themwith a
5 base-pair mismatch control MO (rab5ab MM MO2) and with
uninjected control embryos. Once again the rab5ab MO injected
embryos underwent a slowed epiboly, did not develop a dorsal
organizer and died before the completion of epiboly (Fig S1H) when
compared with both the rab5ab MM MO2 (Fig S1G) and the
uninjected control (Fig S1F). The proportion of embryos that survive
to 30% epiboly is signiﬁcantly (p¼0.002) reduced in embryos injected
with rab5ab MO2 compared to those injected with rab5ab MM MO2
(Fig S1L)
The lack of visible dorsal organiser led us to investigate the mRNA
components of the nodal signalling pathway. By in situ hybridisat-
ion we found that rab5ab MO-injected embryos showed no gsc
(Fig. 3(M)), ﬂh (Fig. 3(O)) or bhik (Fig. 3(Q)), expression compared to
control MO-injected embryos (Fig. 3(L), (N), (P) respectively). There
was some marginal expression of ntl (Fig. 3(S)) in rab5abMO-injected
embryos and reduced expression of ndr1 (Fig. 3(U)) and ndr2
(Fig. 3W) compared with controls (Fig. 3(R), (T), (V) respectively).
Embryos injected with the second rab5abMO also showed disruption
of gsc expression (Fig S1K) while the 5-bp mismatch MO injected
embryos (Fig S1J) and the uninjected control embryos showed normal
expression (Fig S1I). To quantify and validate the in situ results we
performed qRT-PCR on control and rab5ab MO injected embryos at
30% epiboly and shield stage. Empirical distributions of expression are
shown in Fig. 4. For gsc, chd, ntl and ndr1, average expression was
lower in MO-injected embryos, compared to control-injected
embryos (ntl: Likelihood Ratio¼12.4, po0.001; gsc: L.R.¼16.7,
po0.001; chd: L.R.¼4.38, p¼0.037), although this was only the case
at 30% epiboly stage for ndr1 expression (morpholino stage inter-
action: L.R.¼15.6, po0.001). For these measurements transferrin
receptor 1b (tfr1b) was used as a control and showed no signiﬁcant
difference in expression between MO-injected and control-injected
embryos (L.R.¼0.097, p¼0.76).
A role for rab5ab in nodal signalling
To test whether the lack of nodal–responsive gene expression is
speciﬁc to the rab5ab MO we compared expression of gsc in
embryos co-injected with GFP-rab5ab RNA/rab5ab MO with those
injected with a control MO or those injected with rab5ab MO
alone. In embryos injected with GFP-rab5ab RNA/rab5ab MO
(Fig S1C) and those injected with control MO (Fig S1A) we saw
normal gsc expression. In those embryos injected with rab5ab MO
alone (Fig S1B) we failed to see gsc expression.
To ensure the morpholino was speciﬁc we repeated the
experiment using a second morpholino (rab5ab MO2) that binds
to the UTR of rab5ab. Here we saw that the proportion of embryos
that survived to 30% epiboly was signiﬁcantly increased (p¼0.004)
in embryos co-injected with rab5ab RNA/rab5ab MO2 when
compared with those injected with rab5ab MO2 alone (Fig S1L).
gsc expression was also normal in embryos co-injection with
rab5ab RNA/rab5ab MO2 (Fig S1Q) when compared with
E.J. Kenyon et al. / Developmental Biology 397 (2015) 212–224216
Fig. 3. Loss of function of rab5ab. (A) Control embryo at 70% epiboly compared to (B) a 5 ng rab5ab MO-injected embryo at the same time point showing apparent accumulation of
extracellular ﬂuid between the yolk and the cells. (C) Control embryo at shield stage. (D) Animal view and (F) side view of a control-injected embryo at shield stage compared to
(E) animal view and (G) side view of 3 ng rab5ab MO-injected embryos at the same time point. (H) Control-injected embryos at 90% epiboly compared to (I) the same time point in the
3 ng rab5ab MO-injected embryos. (J) 8 somite stage control embryo compared to (K) 3 ng rab5ab MO-injected embryo at the same time point. Expression pattern of gsc in (L) control
MO-injected embryos (n¼40/40) compared to (M) 3 ng rab5abMO-injected embryos (n¼41/41). Expression pattern of ﬂh in (N) control MO-injected embryos (n¼20/20) compared to
(O) 3 ng rab5ab MO-injected embryos (n¼21/21). Expression pattern of bhik in (P) control MO-injected embryos (n¼29/29) compared to (Q) 3 ng rab5ab MO-injected embryos
n¼31/31). Expression pattern of ntl in (R) control MO-injected embryos (n¼40/40) compared to (S) 3 ng rab5abMO-injected embryos (n¼39/39). Lateral view of expression pattern of
ndr1 in (T) control MO-injected embryos (n¼30/30) compared to (U) rab5ab MO-injected embryos (n¼30/30). Lateral view of expression pattern of ndr2 in (V) control MO-injected
embryos (n¼30/30) compared to (W) rab5ab MO-injected embryos (n¼29/29).
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uninjected embryos (Fig S1M) and those injected with rab5ab MM
MO2 (Fig S1N). gsc expression was missing from those embryos
injected with rab5ab MO2 alone (Fig S1P). In addition, when
downstream Nodal signalling was rescued by injection of 25 pg
of activated taram-a RNA (Aoki et al., 2002; Aquilina-Beck et al.,
2007), gsc expression was seen in both rab5ab MO-injected
(Fig S1E) and control embryos (Fig S1D).
The effect of rab5ab on nodal signalling is likely due to
maternal transcripts, as embryos injected with 10 ng of rab5a2
splice MO were comparable to controls at shield stage showing a
visible organizer unlike the rab5a2 morpholino injected embryos.
The rab5a2 splice MO injected embryos also completed epiboly
however by 24 hpf the rab5a2 splice MO injected embryos showed
an accumulation of dead cells across the yolk (Fig S1S) compared
to control injected embryos (Fig S1R). Although the rab5a2 splice
MO injected embryos had massive cell death by 24 hpf, at shield
stage they had a visible organizer, and expression patterns for bhik,
gsc, ntl and chd were similar to controls (Fig S1T-AA)
Wild-type rab5ab was overexpressed in normal embryos by
injecting 1.5 ng of synthetic 50-capped RNA. At 40–50% epiboly, an
accumulation of cells was seen on the animal pole of approxi-
mately one third of the rab5ab RNA-injected embryos (n¼14/41)
(Fig. 5(B)). In the remaining rab5ab RNA-injected embryos, the
embryonic shield appeared larger (n¼27/41). At 24 hpf, approxi-
mately two thirds of the rab5ab RNA-injected embryos appeared
similar to control embryos, except for an enlarged yolk extension
(n¼27/39). The remaining third displayed a reduced body axis and
reduced head size (n¼12/39) (Fig. 5(D)). By 5 dpf, all of the rab5ab
RNA-injected embryos showed a severely shortened body axis and
thicker, less extended yolks (n¼38/38) (Fig. 5F).
To establish whether overexpression of rab5ab affected nodal-
responsive genes, we examined expression of the dorsal markers
chd, gsc and ntl. At 30% epiboly, rab5ab RNA-injected embryos
showed expression of gsc in the ventral region, in addition to the
normal dorsal expression (Fig. 5(H)). Additionally, some rab5ab
RNA-injected embryos expressed ntl in patches in the animal pole
(Fig. 5(P)) in addition to the normal marginal expression. At 50%
epiboly, rab5ab RNA-injected embryos showed ectopic gsc expres-
sion in the animal pole (Fig. 5(J)). At this stage, the embryos
showed no ectopic ntl expression. However, rab5ab RNA-injected
embryos did show abnormal ntl expression, which was expanded
toward the animal pole from the normal marginal expression
domain (Fig. 5(R)). At 70% epiboly, rab5ab RNA-injected embryos
showed additional gsc expression in the animal pole (Fig. 5(L)).
Similarly ntl in rab5ab RNA-injected embryo was ectopically
expressed at the animal pole (Fig. 5(T)). At 90% epiboly rab5ab
RNA-injected embryos continued to show mislocalised expression
of both gsc (Fig. 5(N)) and ntl (Fig. 5(V)). Expression of chd was
unchanged in experimental embryos, compared to the control
injected embryos in 30% (Fig. 5(X)), 50% (Fig. 5(Z)), 70% (Fig. 5(AB))
and 90% epiboly (Fig. 5(AD)).
Further studies of rab5ab function
As injection of rab5ab RNA resulted in an unexpected pattern of
expression of nodal downstream genes ntl and gsc while injection
of rab5ab MO resulted in abolishment of these genes and qRT-PCR
showed a reduction in chd and ndr1 expression, we investigated
the role of rab5ab in the expression of ventral markers wnt8a,
bmp4, vox and bmp2b. Injection of rab5ab MO resulted in wide-
spread expression of wnt8a around the whole margin (Fig. 6(B))
compared to control embryos where expression was excluded
from the dorsal margin (Fig. 6(A)). Measurement of mRNA expres-
sion using qRT-PCR showed the level of wnt8a to be lower
(L.R.¼32.0, po0.001) in rab5ab MO injected embryos compared
to controls (Fig. 4). Injection of rab5ab RNA resulted in the
expression of wnt8a being restricted to the ventral most half of
the embryo (Fig. 6(C)).
In situ hybridisation showed that bmp4 expression in embryos
injected with rab5ab MO was primarily in the margin (Fig. 6(E))
compared to control embryos where bmp4 expression could be
observed over the ventral half of the embryos (Fig. 6(D)). Similarly,
qRT-PCR showed the level of bmp4 to be lower (L.R.¼23.4,
po0.001) in rab5ab MO injected embryos compared to controls
Fig. 4. Quantitative analysis of morpholino activity. Expression of eight genes (ntl, gsc, chd, ndr1, bmp2b, bmp4, wnt8a and tfr1b) at two key developmental stages (30%
epiboly and shield) was quantiﬁed using qRT-PCR, following MO or control injection. Ct data were 1/log2(Ct) transformed to stabilise variance and allow intuitive visual
inspection of the data, i.e. a higher value equates to greater expression. Box-whisker plots show empirical distributions of gene expression for each stage X MO treatment.
Horizontal lines denote median expression and boxes cover the interquartile range. Whiskers extend to 1.5 times the interquartile range, with additional outliers plotted as
points.
E.J. Kenyon et al. / Developmental Biology 397 (2015) 212–224218
(Fig. 4). Injection of rab5ab RNA resulted in the expression of bmp4
being further restricted to the ventral most part of the embryo
(Fig. 6(F)) when compared with controls (Fig. 6(D)). Expression of
vox in embryos injected with rab5ab MO was observed over the
whole animal pole of the embryo (Fig. 6(H)) compared to controls
where the expression was excluded from the dorsal most part of
the embryo (Fig. 6(G)) in embryos injected with rab5ab RNA, vox
expression was excluded from the majority of the dorsal half of the
embryo (Fig. 6(I)).
Expression of bmp2b in embryos injected with rab5ab MO was
observed predominantly in in the margin of the embryo (Fig. 6(K))
compared to controls where the expression was excluded from the
dorsal most part of the embryo only (Fig. 6(J)). Measurement
of bmp2b levels by qRT-PCR showed no signiﬁcant difference
Fig. 5. A role for rab5ab in Nodal signalling. Lateral view of (A) shield stage control injected embryo compared to (B) shield stage 1.5 ng rab5abmRNA overexpressing embryo
(n¼14/41). Lateral view of (C) 24 hpf control injected embryo compared to (D) 24 hpf 1.5 ng rab5abmRNA overexpressing embryo (n¼12/39). Lateral view of (E) 5dpf control
injected embryo compared to (F) 5dpf 1.5 ng rab5ab mRNA overexpressing embryo (n¼38/38). Expression of gsc in control embryos at (G) 30%, (I) 50%, (K) 70% and (M) 90%
epiboly compared to expression of gsc in rab5ab overexpressing embryos at (H) 30% (n¼10/12), (J) 50% (n¼20/21), (L) 70% (n¼8/13) and (N) 90% epiboly (n¼5/10).
Expression of ntl in control embryos at (O) 30%, (Q) 50%, (S) 70% and (U) 90% epiboly compared to expression of ntl in rab5ab overexpressing embryos at (P) 30% (n¼8/12),
(R) 50% (n¼21/22), (T) 70% (n¼9/13) and (V) 90% epiboly (n¼7/10). Expression of chd in control embryos at (W) 30%, (Y) 50%, (AA) 70% and (AC) 90% epiboly compared to
expression of ntl in rab5ab overexpressing embryos at (X) 30% (n¼12/12), (Z) 50% (n¼11/11), (AB) 70% (n¼10/10) and (AD) 90% epiboly (n¼10/10). The gsc expression
patterns are shown as animal pole views as are 30% epiboly ntl expressing embryos and 30% and 50% chd expressing embryos. The remainder of the embryos are shown as a
side view for improved visualisation of expression patterns.
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(L.R.¼0.267, p¼0.61) between embryos injected with rab5ab MO
and controls (Fig. 4). In embryos injected with rab5ab RNA bmp2b
expression was excluded from the majority of the dorsal half of the
embryo (Fig. 6(L)).
Control of epiboly movements by Rab5ab
In rab5ab MO-injected embryos the movement of all tissues
layers was signiﬁcantly delayed. Embryos injected with rab5abMO
Fig. 6. The role of rab5ab in ventral gene expression. Expression of wnt8a in (A) control injected embryos (n¼27/27), (B) rab5ab MO injected embryos (n¼29/29) and (C)
rab5ab RNA injected embryos (n¼41/42) at 30% epiboly. Expression of bmp4 in (D) control injected embryos (n¼17/17), (E) rab5ab MO injected embryos (n¼27/27) and (F)
rab5ab RNA injected embryos (n¼20/20) at 30% epiboly. Expression of vox in (G) control injected embryos (n¼47/47), (H) rab5ab MO injected embryos (n¼32/32) and (I)
rab5ab RNA injected embryos (n¼55/55) at 30% epiboly. Expression of bmp2b in (J) control injected embryos (n¼41/41), (K) rab5ab MO injected embryos (n¼36/36) and (L)
rab5ab RNA injected embryos (n¼41/41) at 30% epiboly. All embryos shown are animal view.
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underwent a slowed epiboly from the outset and slowed further as
epiboly progressed, whereas controls underwent epiboly at a
constant rate over approximately 5 h (Fig. 7(D)). This delay was
initially synchronous but in embryos that survived through later
stages of epiboly, we found that the delayed movement of distinct
layers was out of sync (Fig. 7(A), (B) and (C)). Since epiboly in
zebraﬁsh involves endocytic removal of the yolk cell membrane in
the cells (Betchaku and Trinkaus, 1978; Solnica-Krezel and Driever,
1994; Lepage et al., 2014) we investigated endocytosis in the
rab5ab MO-injected embryos. To measure the endocytosis activity
directly we incubated rab5ab MO-injected embryos and control-
MO injected embryos in a physiological solution containing
biotinylated dextran, then ﬁxed the embryos at three stages.
Control embryos, at dome stage and 30% epiboly, all showed a
ring of staining for biotinylated dextran around the leading edge of
the blastoderm (Fig. 7(E) and (G)). At shield stage, this staining
formed a gradient from the dorsal to ventral side of the embryo
(Fig. 7(I)). In contrast, rab5ab MO-injected embryos showed very
little staining at dome stage, less staining at 30%, and no staining
at shield stage (Fig. 7(F), (H) and (J)).
Despite the defects in endocytosis in the rab5ab MO-injected
embryos, epiboly did proceed but at a slower pace and did not ﬁnish.
This suggested that the microtubules in the yolk were unaffected and
were responsible for epiboly proceeding as far as it did. As cold
depolymerizes microtubules (Jesuthasan and Stahle, 1997), we held
5 ng rab5abMO-injected and control embryos at 20 1C and monitored
for 18 h (Mov S1). Control embryos developed normally (Fig. 7(K), (M),
(O) and (Q)) albeit with some developmental delay, whereas rab5ab
MO-injected embryos arrested and started to die at 13 hpf (10 h in to
monitoring) at sphere to early epiboly stages (Fig. 7(L), (N), (P) and
(R)). rab5ab MO-injected siblings incubated at 28 1C died at the later
stage of 70% epiboly, while control-MO injected siblings incubated
at 28 1C developed normally.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.11.007.
Activity of rab5ab in endocytosis
The mammalian version of RAB5A has been shown to function
as a regulatory factor in the early endocytosis pathway by
stimulating membrane fusion during endocytosis (Gorvel et al.,
1991; Bucci et al., 1992; Stenmark et al., 1994). We investigated the
cell morphology of rab5ab MO-injected cells at the ultrastructural
level (Fig. 8) and found that rab5ab MO-injected cells showed
enlarged, smooth membrane proﬁles with highly irregular shapes
(Fig. 8(B) and (D)), which were not observed in the cells of control-
injected embryos (Fig. 8(A) and (C)). Additionally, the cells of
rab5ab MO-injected embryos had an increased number of what
appear to be large secondary lysosomes (Fig. 8(B) and (D) white
arrows).
Discussion
The RAB5 family has been one of the most extensively studied of
the Rabs (Li and Stahl, 1993; Singer-Kruger et al., 1994; Zerial and
Fig. 7. Roles for rab5ab in endocytosis and epiboly. (A), (B) and (C) Lateral views, (dorsal to the right) of epiboly of cells of the blastoderm (black arrow), enveloping layer (red
arrow) and yolk syncytial layer (green arrow) in a 70% epiboly stage 3 ng rab5ab MO injected embryo in three different focal planes. (D) Graph shows the progression of
epiboly in rab5ab MO-injected embryos (blue line) and in control embryos (red line) (n¼12). Animal view of control embryos at (E) dome (G) 30% epiboly and (I) shield stage
compared to (F) dome (n¼13/17), (H) 30% epiboly (n¼12/13) and (J) shield stage (n¼14/15) in 5 ng rab5ab MO injected embryos. The brown staining shows the uptake of
biotin via endocytosis during epiboly. Control embryos (n¼16/16) subjected to cold shock at (K) 3 hpf, (M) 7.5 hpf, (O) 12.5 hpf and (Q) 14 hpf when compared to rab5ab
MO-injected embryos (n¼14/14) subjected to cold shock at (L) 3 hpf, (N) 7.5 hpf, (P) 12.5 hpf and (R) 14 hpf.
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McBride, 2001). Their role in vesicle trafﬁcking and endocytosis within
the cell is well characterised (Gorvel et al., 1991; Bucci et al., 1992) and,
for this reason, the Rab5 family has been used to understand
signalling in the developing embryo (Scholpp and Brand, 2004;
Hagemann et al., 2009). The transport of signalling factors in and
out of a cell is integral to the patterning of the embryo, with the Rab5
family being used to understand the endocytosis that control this
signalling. However, comparative studies between the genes within
the rab5 family have not been undertaken in whole animal systems
previously and the possibility that the various rab5 genes perform
different developmental roles is hitherto unexplored. We sought to
distinguish the possibility that rab5 genes are functionally redundant
with overlapping activities, from the possibility that rab5 genes have
divergent functions during development.
It was important ﬁrst to account for all of the rab5 gene family
members in zebraﬁsh and we found that there are four rab5 family
members: rab5aa, rab5ab, rab5b and rab5c, which compares with
the three rab5 genes in human. The duplicated rab5a gene is
particularly interesting, since the knockdown of each of these two
genes resulted in very different phenotypes in our study, whereas
rab5b and rab5c showed similar phenotypes. Speciﬁcally, rab5aa
MO-injected embryos were phenotypically indistinguishable from
controls, while rab5ab MO-injected embryos showed an early
lethal phenotype.
The lack of an abnormal phenotype associated with rab5aa
knockdown suggests that it is redundant for early development,
although it may be required for post-embryonic development.
Indeed, expression data suggests a subtle role for rab5aa in later
brain development (Fig. 2) with other animal models showing a
role for Rab5a in the brain (Allende and Weinberg, 1994; de Hoop
et al., 1994; Sadler et al., 2007; Rosenegger et al., 2010). In rats,
Rab5a has been detected in axons and dendrites, with Rab5a
co-localised with synaptophysin-containing vesicles, suggesting a
role for Rab5a in axonal and dendritic endocytosis (De Hoop et al.,
1994). Our results show expression of rab5aa in zebraﬁsh is
restricted to discrete parts of the brain and spinal cord.
We found that knockdown of rab5b and rab5c lead to similar
abnormal phenotypes. Speciﬁcally, MO-injected embryos showed
no obviously abnormal phenotype through gastrulation but by
24 hpf had thin and bar-shaped somites, forebrain defects and cell
death, suggesting a later role for these rab5 genes (Fig. 2). In situ
hybridisation shows rab5b expression from 1–13 somites in the
YSL and pronephric mesoderm, then after 20 somites in the YSL,
pronephric ducts and dorsal telencephalon (Thisse and Thisse,
2004). Taken together, these data imply a role for rab5b in nervous
system development. In rat hippocampal cultures, Rab5b has been
shown to be upregulated by the neuroprotective agent DHPG
(Blaabjerg et al., 2003). Neuroprotection by DHPG against
NMDA-mediated injury may involve facilitation of NMDA receptor
endocytosis stimulated by a DHPG-induced increase in Rab5b
synthesis and may therefore play a role in synaptic plasticity
(Arnett et al., 2004; Baskys et al., 2007).
Knockdown of rab5c, although phenotypically similar to knock-
down of rab5b, suggests that rab5c and rab5b may have different
roles in development. In situ hybridisation data for rab5c showed
expression from the 20 somites to the Prim-15 stage in the
intermediate cell mass of mesoderm, the site of primitive hema-
topoiesis (Detrich et al., 1995; Thisse and Thisse, 2004). At later
stages of development, rab5c expression is seen in axial vascula-
ture and blood (Thisse and Thisse, 2004). A previous study of
Fig. 8. Activity of rab5ab in endocytosis. Transverse sections of cells of the leading edge of the enveloping layer from a 3 ng control-injected embryo 80% epiboly (A) and (C),
a 3 ng rab5ab MO injected embryo (ﬁxed at 40% epiboly but when control embryos were at 80% (B) and (D). White arrows show large secondary lysosomes with
membranous contents. (A) and (B) are at 10,000 ; and (C) and (D) are at 18,750 .
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knock down of rab5c reported cell death over the whole embryo
resulting in reduced yolk extension and expanded hindbrain at
28 hpf and at 56 hpf there was signiﬁcant cell death, resulting in
small head and eyes and bending of the body axis (Kalen et al.,
2009). This result corresponds well with what we have observed,
which included shortened axis and brain cell death. Taken
together these observations suggest a distinct function for rab5c
in mesoderm development at the late gastrula stage as it has been
observed that Wnt11 functions in gastrulation by controlling cell
cohesion through Rab5c and E-cadherin (Ulrich et al., 2005).
Depletion of rab5ab led to loss of the dorsal organiser and
embryonic lethality by 90% epiboly stage. We therefore examined
the expression of the nodal genes ndr1 and ndr2 and their down-
stream genes gsc, ﬂh and ntl and found all but ntl to be abolished in
rab5ab MO-injected embryos. Further this loss of expression for
gsc, could be reversed by injection of synthetic rab5ab or taram-a
mRNA. Indeed injection of large amounts of rab5ab RNA resulted
in ectopic expression of downstream genes gsc and ntl but not the
dorsal marker gene chd. It also resulted in embryos with larger
organizers and shorter body axes. Interestingly ntl showed no
ectopic expression at shied stage but instead showed expansion of
the margin into the animal pole. This and the presence of ntl in
rab5ab MO injected embryos could be explained by the fact that
the expression of ntl is not entirely nodal-related, but is also
regulated by Wnt and BMP signalling (Harvey et al., 2010). We
therefore investigated whether bmp and wnt signalling might be
affected in embryos overexpressing rab5ab or in those injected
with a rab5ab morpholino. Although wnt8a was present around
the whole margin of the embryo total wnt8a expression was lower
in embryos injected with rab5ab MO. In embryos injected with
rab5ab RNA expression of wnt8a was restricted to the ventral half
of the embryo. Expression of bmp family members was more
complex and while bmp4 expression was decreased in rab5ab MO
injected embryos, there was no signiﬁcant change in bmp2b
expression in these embryos. Expression of bmp4, bmp2b and vox
showed abnormal distribution both in embryos overexpressing
rab5ab and those injected with rab5ab MO. It is possible that
bmp2b may be driving ntl expression in those embryos lacking
rab5ab. All together this shows an important role for rab5ab in
nodal signalling and dorsal-ventral patterning.
In addition to its role in Nodal signalling we ﬁnd rab5ab plays a
role in cell movement within the developing embryo. In rab5ab
MO-injected embryos, epiboly is slowed. This is understandable, as
RAB5 family members are known for their role in endocytosis
(Bucci et al., 1995). Epiboly is thought to be the result of two
processes, endocytosis at the margin, which moves cells over the
yolk, and the contraction of the actin cytoskeleton within the yolk
cell proper (Solnica-Krezel and Driever, 1994). Therefore cell
movements within the developing embryo are disrupted when
endocytosis associated with epiboly is diminished (Fig. 6) (Lepage
et al., 2014) but when we further disrupt the microtubule
cytoskeleton in the yolk, epiboly is not rescued. Moreover, it
appears that certain events such as closing of the actin ring at
the end of epiboly are independent of the epiboly process as this
occurs whether epiboly completes or not. It is also possible that
the start of gastrulation may be independent of the stage of
epiboly, as marginal expression of bmp4 and bmp2b is seen in
embryos injected with rab5ab MO at 30% epiboly where as in
control embryos this is not be observed until the embryos enter
gastrulation at 50% epiboly.
Non-embryonic nodal transcripts in the YSL can mediate inter-
action between the embryonic and non-embryonic tissues that
maintain nodal related gene expression in the margin (Fan et al.,
2007). Additionally ndr1 function is required in the YSL to induce
the morphological shield, and the YSL is a source of Nodal signals
that is independent of the population in the overlying blastomeres.
Both Nodal ligands Ndr1 and Ndr2 are expressed by the YSL and
induce ndr1 mRNA expression in the overlying blastomeres. It has
been suggested that the three non-embryonic sources of Nodal
ligands, maternal ndr1 and non-embryonic ndr1 and ndr2, account
for the complete spectrum of early nodal signalling and, therefore,
organizer speciﬁcation and induction of mesoderm and endoderm
(Hong et al., 2011). A recent paper (Kumari et al., 2013) has shown
that maternal control of Nodal signalling is via the conserved
Y box-binding protein 1 (ybx1) and that maternal-effect mutations
in zebraﬁsh ybx1 lead to deregulated Nodal signalling, gastrulation
failure, and embryonic lethality. The paper suggests that Ybx1
prevents ectopic Nodal activity.
Our data and the published literature lead us to propose that
Nodal signals emanating from the YSL are taken up by blastomeres
via endocytic vesicles under the control of Rab5ab. This model
could explain the abnormal accumulation of ﬂuid we observe
between the blastoderm and the yolk in rab5ab MO-injected
embryos (Fig. 3(B)). In addition, rab5ab over–expressing embryos
showed ectopic expression, as well as normal expression of the
markers of Nodal signalling gsc and ntl. This would be consistent
with the model if early expression of these genes was controlled
by maternal and/or non-embryonic sources of Nodal ligands but
later expression was due to embryonic sources. An alternative
scenario is that that maternal rab5ab is somehow involved in the
ybx1 maternal control of Nodal signalling leading to deregulation
of nodal signalling, its downstream genes and deregulation of DV
patterning.
It was recently shown that zebraﬁsh dynamin, a GTPase
required for receptor-mediated endocytosis, plays a fundamental
role within the blastoderm during epiboly. Dynamin is required for
completion of epiboly and maintains epithelial integrity and the
transmission of tension across the EVL (Lepage et al., 2014).
Embryos lacking dynamin show a similar phenotype to those we
have shown lacking rab5ab. In Drosophila, remodelling of the
apical surface during epithelial morphogenesis has been shown
to be regulated by dynamin and the Rab5-effector Rabankyrin-5
(Fabrowski et al., 2013) while research in the sea urchin embryo
suggests that dynamin-mediated endocytosis acts as a sink to limit
the range of Nodal signalling (Ertl et al., 2011). In sea urchins,
inhibition of dynamin, resulted in embryos that became radialised
and phenocopied embryos that overexpress nodal. Although this
does not correspond with what we see with knock down of rab5ab
it does suggest a possible relationship between rab5ab, dynamin
and nodal which is worthy of further study.
In conclusion, the key ﬁnding of this study is the crucial role for
Rab5ab in early nodal signalling and organizer speciﬁcation in the
developing zebraﬁsh embryo. It should also be noted that various
members of the Rab5 family are associated with different roles in
early embryonic development. Corroborative evidence fromwhole
organism phenotypic analysis in zebraﬁsh is more consistent with
functional divergence, than redundancy, between rab5 genes.
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